Your session is about to expire
← Back to Search
Abbreviated MRI for Colon Cancer with Liver Metastasis
N/A
Recruiting
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of colorectal cancer, biopsy proven
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights
Study Summary
This trial will compare the accuracy of detecting colon cancer liver metastases between a regular MRI with the contrast agent Primovist and a shortened MRI with Primovist. The economic impact of using Primovist will also be assessed.
Who is the study for?
This trial is for adults over 18 with colorectal cancer and liver metastases, who've had a CT scan within the last month. They must be able to undergo MRI and have normal kidney function. It's not for those with widespread liver metastases, severe liver issues, incompatible implants, extreme claustrophobia unaided by medication, exceeding MRI table weight limits or pregnant women.Check my eligibility
What is being tested?
The study compares two types of MRIs using Primovist contrast: a full-length traditional MRI against a new shortened protocol to see if it can detect colon cancer spread to the liver just as well but faster and cheaper.See study design
What are the potential side effects?
Potential side effects may include allergic reactions to the gadolinium-based contrast agent used in MRIs. However, this risk is low especially since patients with known severe allergies are excluded from participation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with colorectal cancer through a biopsy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Diagnostic accuracy of abbreviated versus full MRI protocol
Secondary outcome measures
Cancer specific survival at 1 year post abbreviated versus full MRI protocol
Cost of abbreviated versus full MRI protocol
Diagnostic accuracy of abbreviated and full MRI protocol versus CT
+4 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Abbreviated ProtocolExperimental Treatment1 Intervention
Shortened Primovist MRI
Group II: Full ProtocolActive Control1 Intervention
Routine Primovist MRI
Find a Location
Who is running the clinical trial?
BayerIndustry Sponsor
2,240 Previous Clinical Trials
25,332,477 Total Patients Enrolled
Lawson Health Research InstituteLead Sponsor
659 Previous Clinical Trials
413,432 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My liver cancer cannot be removed with surgery.My liver is not working well (ALBI grade 3).I have been diagnosed with colorectal cancer through a biopsy.My kidney function is low, with an eGFR below 30.I am 18 years old or older.I have severe claustrophobia that medication does not help.I weigh less than the maximum limit for an MRI table.
Research Study Groups:
This trial has the following groups:- Group 1: Abbreviated Protocol
- Group 2: Full Protocol
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruitment for this investigation still open?
"According to the information featured on clinicaltrials.gov, this particular trial is not presently searching for patients. It was first posted in May 1st 2022 and its most recent update was recorded on March 29th 2022. However, there are 637 other trials that are actively seeking patient enrollment at this time."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger